ArticleJournal of gastrointestinal oncology2026
Development and validation of prognostic nomograms for intrahepatic cholangiocarcinoma with concomitant hepatolithiasis after radical resection.
Article in Journal of gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with intrahepatic cholangiocarcinoma (ICC) and concomitant hepatolithiasis constitute a distinct clinical subgroup, but prognostic models for this population are scarce. We therefore developed and validated nomograms to predict postoperative recurrence-free survival (RFS) and overall survival (OS). Methods: A total of 335 patients with ICC and concomitant hepatolithiasis who underwent radical resection were retrospectively enrolled. The cohort was randomly divided into a training cohort (n=161) and an internal validation cohort (n=69) from 230 patients, while 105 patients from an external institution constituted an independent validation cohort. Multivariable Cox regression analysis identified independent prognostic factors for RFS and OS. Nomograms based on these factors were subsequently constructed and validated using calibration curves, time-dependent receiver operating characteristic (ROC) curves, and C-index. Results: Vascular invasion, tumor number, lymph node metastasis, tumor size, carcinoembryonic antigen (CEA), microfibrillar-associated protein 4 (MFAP4), and albumin-bilirubin (ALBI) grade were independent predictors of RFS, while vascular invasion, tumor number, lymph node metastasis, carbohydrate antigen 19-9 (CA19-9), CEA, MFAP4, and ALBI grade were independently associated with OS. The resulting nomograms demonstrated good calibration and discrimination. In the training cohort, the C-index for RFS and OS were 0.840 and 0.852, respectively; these values were 0.823 and 0.832 in the internal validation cohort, and 0.862 and 0.870 in the external validation cohort. Conclusions: The developed nomograms accurately predicted postoperative RFS and OS in patients with ICC and concomitant hepatolithiasis, thereby supporting individualized risk stratification and postoperative management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.